3. Summary
Global Market Direct’s pharmaceuticals report, “Peregrine Pharmaceuticals,
Inc. - Product Pipeline Review - 2012” provides data on the Peregrine
Pharmaceuticals, Inc.’s research and development focus. The report includes
information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Peregrine Pharmaceuticals, Inc.’s corporate
website, SEC filings, investor presentations and featured press releases,
both from Peregrine Pharmaceuticals, Inc. and industry-specific third party
sources, put together by Global Markets Direct’s team.
4. Scope
- Peregrine Pharmaceuticals, Inc. - Brief Peregrine Pharmaceuticals, Inc. overview
including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of Peregrine Pharmaceuticals, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Reasons to buy
- Evaluate Peregrine Pharmaceuticals, Inc.’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of Peregrine Pharmaceuticals, Inc. in its therapy areas
of focus.
- Identify new drug targets and therapeutic classes in the Peregrine Pharmaceuticals,
Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps.
5. Table of Contents :
List of Tables 5
List of Figures 6
Peregrine Pharmaceuticals, Inc. Snapshot 7
Peregrine Pharmaceuticals, Inc. Overview 7
Key Information 7
Key Facts 7
Peregrine Pharmaceuticals, Inc. – Research and Development Overview 8
Key Therapeutic Areas 8
Peregrine Pharmaceuticals, Inc. – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Pipeline Products – Combination Treatment Modalities 13
Peregrine Pharmaceuticals, Inc. – Pipeline Products Glance 14
Peregrine Pharmaceuticals, Inc. Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Peregrine Pharmaceuticals, Inc. – Early Stage Pipeline Products 16
Pre-Clinical Products/Combination Treatment Modalities 16
Peregrine Pharmaceuticals, Inc. – Drug Profiles 17……………….
6. Please follow link if you want More Related
Reports :
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product
Pipeline Review – 2012&PubId=&pagenum=1
